|
Marti S, Galan FM, Casero JM, Merino J, Rubio G. Characterization of trisomic natural killer cell abnormalities in a patient with constitutional trisomy 8 mosaicism. Pediatr Hematol Oncol. 2008 Mar;25(2):135-46. doi: 10.1080/08880010801890135. PubMed PMID: 18363181.
AÑO: 2008; IF: 1.2
|
18363181
|
Rubio G, Ferez X, Mora A, Galvez J, Chicano A, Garcia-Penarrubia P. Beta1 integrin triggering affects leukemic cell line sensitivity to natural killer cells. Cancer Immunol Immunother. 2002 May;51(3):130-8. doi: 10.1007/s00262-002-0264-8. Epub 2002 Feb 28. PubMed PMID: 11941451.
AÑO: 2002; IF: 6.63
|
|
Garcia-Penarrubia P, Lorenzo N, Galvez J, Campos A, Ferez X, Rubio G. Study of the physical meaning of the binding parameters involved in effector-target conjugation using monoclonal antibodies against adhesion molecules and cholera toxin. Cell Immunol. 2002 Feb;215(2):141-50. doi: 10.1016/s0008-8749(02)00023-0. PubMed PMID: 12202151.
AÑO: 2002; IF: 4.178
|
|
Cabrera L, Galvez J, Lajarin F, Rubio G, Aparicio P, Garcia-Penarrubia P. Conjugation between cloned human NK cells (H7.8) and K562/MOLT4 tumor cell systems: saturability, binding parameters, and population distribution of conjugates. Cell Immunol. 1996 Apr 10;169(1):133-41. doi: 10.1006/cimm.1996.0101. PubMed PMID: 8612286.
AÑO: 1996; IF: 3.7
|
|
Hernandez-Caselles T, Martinez-Esparza M, Sancho D, Rubio G, Aparicio P. Interleukin-7 rescues human activated T lymphocytes from apoptosis induced by glucocorticoesteroids and regulates bcl-2 and CD25 expression. Hum Immunol. 1995 Jul;43(3):181-9. doi: 10.1016/0198-8859(94)00168-p. PubMed PMID: 7558935.
AÑO: 1995; IF: 3.1
|